What is the ticker symbol for Psyence Biomedical?

Psyence Biomedical trades under the ticker PBM on NASDAQ.

What sector does Psyence Biomedical operate in?

Psyence Biomedical is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze PBM in a portfolio?

PortView shows PBM's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Psyence Biomedical (PBM) Stock Analysis

NASDAQHealthcareBiotechnology

$4.35-0.46%

1-year price historyRange $2.23 – $31.80

52-week range$4.35

$1.92$216.41

What Psyence Biomedical does

Psyence Biomedical Ltd. is dedicated to advancing psychedelic medicines formulated from botanical psilocybin. The firm is actively exploring natural psilocybin as a potential therapy for adjustment disorder experienced by patients with an incurable cancer diagnosis undergoing palliative care. Its leading investigational drug, PEX010, a capsule made with naturally sourced psilocybin, is currently in a Phase IIb clinical study. This product is being developed to treat anxiety, depression, and associated conditions such as post-traumatic stress disorder (PTSD), stress, grief, and adjustment disorder, especially in a palliative care context. Psyence Biomedical has partnered with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010, utilizing psilocybin-assisted psychotherapy for adjustment disorder arising from incurable cancer. Additionally, the company holds a strategic alliance with PsyLabs for the manufacturing of Ibogaine. Headquartered in Toronto, Canada, Psyence Biomedical Ltd. functions as a subsidiary of Psyence Group Inc.

Key metrics

Market cap

$82,733

P/E (TTM)

-0.01

EPS (TTM)

$-393.10

Beta

1.67

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$3.37

200-day avg

$14.87

52-week high

$216.41

52-week low

$1.92

CEO

Jody Aufrichtig

ETFs linked to PBM

Broad-market and Healthcare sector ETFs an investor holding Psyence Biomedical is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how PBM fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze PBM in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Psyence Biomedical?: Psyence Biomedical trades under the ticker PBM on NASDAQ.
Which exchange is PBM listed on?: PBM is listed on NASDAQ.
What sector does Psyence Biomedical operate in?: Psyence Biomedical is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze PBM in a portfolio?: PortView shows PBM's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.